TP53 and COVID-19: Bordoni et al., have recently shown that PBMCs from COVID-19 patients have a high expression of p53 and significantly decreased expression of SIRT1, together with elevated levels of proinflammatory cytokines IL-1β, TNF-α, IL-8, and IL-6.